Skip to content

Clinical trials

Completed Phase 1 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 1 Status: Completed Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20041
20052
20062
20076
20082
20095
20102
20113
20122
20134
20146
20154
20165
20177
20186
20194
20201
20213
20225
20237
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen14
GlaxoSmithKline8
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)5
Bristol-Myers Squibb4
Pfizer3
Biogen2
Cugene Inc.2
Human Genome Sciences Inc.2
Medical University of South Carolina2
RemeGen Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic85
Autoimmune Diseases8
Lupus Erythematosus, Cutaneous6
Lupus Nephritis6
Arthritis, Rheumatoid4
Connective Tissue Diseases4
Dermatomyositis4
Immune System Diseases4
Sjogren's Syndrome4
Inflammation3

Trials

Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.